Search result for

MIMS Reference System is the hallmark of drug information for over 40 years in Asia-Pacific. It is the most advanced, complete and up-to-date information source on available products. The MIMS portfolio of publications includes: Subscribe to MIMS Reference System

MIMSMIMS

* Independently compiled handy reference of essential and concise information on available medicinal products.

* Contents:
  • Essential product information by pharmacological class: trade name, active ingredients, manufacturer, distributor, drug regulation, indications, dosage, contraindications, precautions, adverse reactions, drug interactions, presentations, prices
  • Useful clinical information, where available: pregnancy safety category & advice, pre- and post-prandial advice, cross-reference to full prescribing information in MIMS Annual
  • Company Directory with contact details of manufacturers, marketers and distributors
  • Detailed information and launch dates of new products in New Preparations section
* Country Editions:
  • MIMS China
  • MIMS Hong Kong
  • MIMS Indonesia
  • MIMS Malaysia
  • MIMS Philippines
  • MIMS Singapore
  • MIMS Thailand
  • MIMS Vietnam
Subscribe to MIMS Reference System

MIMS AnnualMIMS Annual

* Compendium of full prescribing information cross-referenced to MIMS. All prescribing information is approved by the various regulatory authorities in the region, as applicable.

* Contents:
  • Detailed product information by brand name: mechanism of action, indications, dosage, overdosage, contraindications, warnings, precautions, interactions, adverse effects, and many more
  • Product identification: photographic images of medicinal products, arranged by physical characteristics such as colour, shape and size, for easy identification
  • Company Product index: summary tables of companies' products with their corresponding brand/generic names, dosage form & packaging, MIMS class, ATC code and description
* Updated annually

* Country Editions
  • MIMS Annual China
  • MIMS Annual Hong Kong
  • MIMS Annual Indonesia
  • MIMS Annual Malaysia
  • MIMS Annual Myammar
  • MIMS Annual Philippines
  • MIMS Annual Singapore
  • MIMS Annual Thailand
  • Vidal Vietnam
Subscribe to MIMS Reference System

MIMS Specialty EditionsMIMS Specialty Editions

* Contents:
  • Disease Management Charts for common specialty-relevant disorders, showing alternative diagnosis, treatment plans and dosage guidelines for recommended drugs
  • Triple indices - Brand and Generic Name Index, Disease Index, and Pharmacological Class Index: systematically help in the search for relevant drug groups, diseases, brands and generics.
* Available titles
  • MIMS Antimicrobial
  • MIMS Cardiology
  • MIMS Cardiometabolic Risk Management
  • MIMS Dermatology
  • MIMS Endocrinology
  • MIMS Gastroenterology & Hepatology
  • MIMS Internal Medicine
  • MIMS Neurology & Psychiatry
  • MIMS Obstetrics & Gynecology
  • MIMS Ophthalmology & Otolaryngology
  • MIMS Respirology
  • MIMS Rheumatology, Allergy & Immunology
  • MIMS Pediatrics
Subscribe to MIMS Reference System

MIMS PharmacyMIMS Pharmacy

* MIMS for pharmacists and pharmacy assistants

* Contents:
  • Essential product information: name, contents, manufacturer, distributor, drug regulation, indications, dosage, contraindications, precautions, adverse reactions, drug interactions, presentations, prices
  • Articles on commonly referred health conditions, each article providing: general information about the condition, warning signs, advice for customers, selling notes, treatment options
  • Company Directory with contact details of manufacturers and distributors
* Updated annually

* Country Editions
  • MIMS Pharmacy Hong Kong
  • MIMS Pharmacy Indonesia (MIMS Petunjuk Konsultasi)
  • MIMS Pharmacy Malaysia
  • MIMS Pharmacy Philippines
  • MIMS Pharmacy Thailand
  • MIMS Pharmacy Vietnam
Subscribe to MIMS Reference System
Drug Updates
New Molecules
 Aloxi Benlysta
 Simponi Zytiga

New Formulations
 CoPlavix

Question Of The Month
Which of the following topics associated with diabetes, obesity and CVD are you most interested to learn about?
survey
Please wait...